Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Clinuvel Pharmaceuticals Limited (CUV)
  6. Change in Directors' Interest

Clinuvel Pharmaceuticals Limited (ASX: CUV) - Directors' Interest

Current share price for CUV : $14.990 0.1 (0.67%)

Under ASX rules all Directors of a listed company, including Clinuvel Pharmaceuticals Limited (CUV), must disclose any shares they buy or sell in their own company - either directly or indirectly - within 5 business days of the transaction. If you are looking to find which Directors are buying or selling their own shares, other than Clinuvel Pharmaceuticals Limited (CUV), please use our Change in Directors' Interest tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Change of shareholding announcements for Clinuvel Pharmaceuticals Limited (CUV)

Search all Changes
Date Director Buy/Sell Security Type Value Qty Trade
Price		 Current Price Price
Change		 Price
7D Avg		 Price
30D Avg		 Current Volume Volume
7D Avg		 Volume
30D Avg
19 Sep 2023 WOLGEN, Philippe Buy Direct Shares $29,814 1,850 $16.116 $14.990 -$1.126 $14.792 $15.026 106,329 114,854.8 152,799.15
26 Jun 2023 WOLGEN, Philippe Buy Direct Shares $27,147 1,532 $17.720 $14.990 -$2.730 $14.792 $15.026 106,329 114,854.8 152,799.15
4 Nov 2022 ROSENFELD, Jeffrey Buy Indirect Shares $5,832.00 300 $19.440 $14.990 -$4.450 $14.792 $15.026 106,329 114,854.8 152,799.15
16 Jun 2022 SHANAHAN, Brenda Sell Indirect Shares $210,536 15,000 $14.036 $14.990 $0.954 $14.792 $15.026 106,329 114,854.8 152,799.15
7 Jun 2022 SHANAHAN, Brenda Sell Indirect Shares $355,606 22,392 $15.881 $14.990 -$0.891 $14.792 $15.026 106,329 114,854.8 152,799.15
10 May 2022 WOLGEN, Philippe Buy Indirect Shares $16,143 1,000 $16.143 $14.990 -$1.153 $14.792 $15.026 106,329 114,854.8 152,799.15
6 May 2022 LIKIERMAN, Andrew Buy Direct Shares $9,068.92 1,000 $9.069 $14.990 $5.921 $14.792 $15.026 106,329 114,854.8 152,799.15
22 Mar 2022 WOLGEN, Philippe Sell Indirect Shares $1,132,006 55,606 $20.358 $14.990 -$5.368 $14.792 $15.026 106,329 114,854.8 152,799.15
25 Feb 2022 ROSENFELD, Jeffrey Buy Indirect Shares $9,263.50 485 $19.100 $14.990 -$4.110 $14.792 $15.026 106,329 114,854.8 152,799.15
30 Jun 2021 WOLGEN, Philippe Sell Indirect Shares $3,748,583 122,675 $30.557 $14.990 -$15.567 $14.792 $15.026 106,329 114,854.8 152,799.15
24 Jun 2021 SHANAHAN, Brenda Sell Indirect Shares $691,771 25,000 $27.671 $14.990 -$12.681 $14.792 $15.026 106,329 114,854.8 152,799.15
31 May 2021 WOLGEN, Philippe Sell Indirect Shares $3,127,366 102,700 $30.451 $14.990 -$15.461 $14.792 $15.026 106,329 114,854.8 152,799.15
3 Mar 2021 WOLGEN, Philippe Sell Indirect Shares $2,564,744 104,000 $24.661 $14.990 -$9.671 $14.792 $15.026 106,329 114,854.8 152,799.15
2 Mar 2021 ROSENFELD, Jeffrey Buy Indirect Shares $14,898 670 $22.236 $14.990 -$7.246 $14.792 $15.026 106,329 114,854.8 152,799.15
10 Sep 2020 SMITH, Susan (Sue) Buy Direct Shares $8,988.00 420 $21.400 $14.990 -$6.410 $14.792 $15.026 106,329 114,854.8 152,799.15
3 Dec 2019 ROSENFELD, Jeffrey Buy Indirect Shares $29,988 1,093 $27.437 $14.990 -$12.447 $14.792 $15.026 106,329 114,854.8 152,799.15
2 Jul 2018 BLIJDORP, Willem Buy Indirect Shares $13,599,730 1,359,973 $10.000 $14.990 $4.990 $14.792 $15.026 106,329 114,854.8 152,799.15
19 Dec 2016 MCLIESH, Stanley Sell Indirect Shares $7,004.00 898 $7.800 $14.990 $7.191 $14.792 $15.026 106,329 114,854.8 152,799.15
12 Dec 2016 MCLIESH, Stanley Sell Indirect Shares $364,431 47,328 $7.700 $14.990 $7.290 $14.792 $15.026 106,329 114,854.8 152,799.15
22 Dec 2014 SHANAHAN, Brenda Issued Indirect Shares $50,000 11,962 $4.180 $14.990 $10.810 $14.792 $15.026 106,329 114,854.8 152,799.15
22 Dec 2014 WOLGEN, Philippe Issued Indirect Shares $150,000 35,866 $4.182 $14.990 $10.808 $14.792 $15.026 106,329 114,854.8 152,799.15
22 Dec 2014 ISHAG, Elie Issued Direct Shares $50,000 11,962 $4.180 $14.990 $10.810 $14.792 $15.026 106,329 114,854.8 152,799.15
29 Jun 2012 WOLGEN, Philippe Buy Direct Shares $95,280 59,500 $1.601 $14.990 $13.389 $14.792 $15.026 106,329 114,854.8 152,799.15
16 Nov 2011 ISHAG, Elie Issued Related Securities 50,000 $0.000 $14.990 $14.990 $14.792 $15.026 106,329 114,854.8 152,799.15
16 Nov 2011 MCLIESH, Stanley Issued Related Securities 80,000 $0.000 $14.990 $14.990 $14.792 $15.026 106,329 114,854.8 152,799.15
16 Nov 2011 SHANAHAN, Brenda Issued Related Securities 50,000 $0.000 $14.990 $14.990 $14.792 $15.026 106,329 114,854.8 152,799.15
16 Nov 2011 WOOD, Lawrence Issued Related Securities 50,000 $0.000 $14.990 $14.990 $14.792 $15.026 106,329 114,854.8 152,799.15
19 Oct 2011 WOOD, Lawrence Buy Direct Shares $96,015 60,000 $1.600 $14.990 $13.390 $14.792 $15.026 106,329 114,854.8 152,799.15
19 Nov 2009 WOOD, Lawrence Buy Direct Shares $58,000 200,000 $0.290 $14.990 $14.700 $14.792 $15.026 106,329 114,854.8 152,799.15
31 Jul 2009 WOOD, Lawrence Buy Direct Shares $32,165 100,000 $0.322 $14.990 $14.668 $14.792 $15.026 106,329 114,854.8 152,799.15
17 Nov 2008 WOOD, Lawrence Buy Direct Shares $25,025 100,000 $0.250 $14.990 $14.740 $14.792 $15.026 106,329 114,854.8 152,799.15
  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.